ADVERTISEMENT

Leadership

Execs On The Move: December 2024

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Trump’s US FDA Reforms Need Center Director, Staff Support To Succeed, Former Leaders Say

Former FDA commissioners Mark McClellan and Scott Gottlieb, former acting commissioner Janet Woodcock and current commissioner Robert Califf offered advice on successfully implementing reforms and preventing a mass exodus of FDA employees as inklings emerge that the Trump team is already engaged on this front.

CDER Director Patrizia Cavazzoni Retires

Cavazzoni, who led the drugs center four-and-a-half years, decided on her own to retire at this time, sources said. The decision may have been a preemptive move knowing her time as head of CDER would have been limited, or at the very least highly challenging, under the new administration.

Who’s Hired? Medicines For Europe Names Stada’s Eder As President

Medicines for Europe names a new president, the IGBA reveals its latest chair, and Chanelle and Xbrane announce fresh faces in key roles, in our latest round-up of off-patent industry appointments.

Stada Makes Chairman Appointment Laying Groundwork For IPO

Stada has made the strongest indication yet that it is preparing for an initial public offering, appointing Andreas Fibig as independent chairman of a board of directors that will be established “in the event of an IPO.”

Stada Chairman Appointment Lays Groundwork For IPO

Stada has made the strongest indication yet that it is preparing for an initial public offering, appointing Andreas Fibig as independent chairman of a board of directors that will be established “in the event of an IPO.”

US Consumer Health People Moves: Perrigo Science And Haleon US Customer Chiefs, More

Volleyball great Gabby Reece promotes Stemregen Sport; eye care pharma Harrow changes scientific lead; sisters partner to launch Renew-V vaginal moisturizer; Haleon tabs former Unilever executive as chief customer officer; and former Bayer executive leads Perrigo’s expanded scientific office.

McGuffin Moving To Senior Advisor At AHPA After More Than 25 Years At Helm

AHPA’s significant legislative victories included enactment of Dietary Supplement and Nonprescription Drug Consumer Protection Act in 2006 to establish a serious adverse event reporting law for vitamin, mineral and supplement products.

Five Themes For Korean Biopharma In 2025

Scrip picks five key themes that dominated biopharma developments in 2024 and look set to continue to influence the industry throughout this year.